Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Johnson and Johnson
Daiichi Sankyo
Fuji
Deloitte
Merck
QuintilesIMS
Argus Health
McKesson

Generated: May 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 084944

« Back to Dashboard

NDA 084944 describes ALPHACAINE, which is a drug marketed by Carlisle and is included in six NDAs. Additional details are available on the ALPHACAINE profile page.

The generic ingredient in ALPHACAINE is epinephrine; lidocaine hydrochloride. There are nineteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.
Summary for 084944
Tradename:ALPHACAINE
Applicant:Carlisle
Ingredient:lidocaine
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 084944

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:OINTMENT;TOPICALStrength5%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Deloitte
Boehringer Ingelheim
Harvard Business School
Farmers Insurance
Baxter
QuintilesIMS
US Department of Justice
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.